CD103 binds to the epithelial cell marker E-cadherin; this binding determines the retention of TRM cells in epithelial tumor islets and the further maturation of cytotoxic immune synapse with specific cancer cells, resulting in T-cell receptor (TCR)–dependent target cell killing. Here, ITGAE is linked to cancer.